Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 VERITAC-2 clinical trial (NCT05654623) evaluating vepdegestrant monotherapy versus ...
Arvinas & Pfizer announce positive topline results from phase 3 VERITAC-2 clinical trial: New Haven, Connecticut Wednesday, March 12, 2025, 10:00 Hrs [IST] Arvinas, Inc., a clinic ...
Trump pushes ahead with tariffs after stock market has worst day of 2025 amid recession fears: Live updates - Trade war ...
Shares in US biotech Arvinas were more than 50% lower, and those in pharma giant Pfizer down 2%, at the mid-point of ...
The applied physicist explains how the structure of 52,000-year-old genes hint at the biology of an extinct animal ...
VERITAC-2 achieved its primary endpoint in the estrogen receptor 1-mutant population, demonstrating statistically significant and clinically meaningful improvement in progression-free survival - - ...
Cannes Film Festival is just two months away, and speculation is building that new features from Paul Thomas Anderson, Park ...
VERITAC-2 achieved its primary endpoint in the estrogen receptor 1-mutant population, demonstrating statistically significant and clinically ...
The Interior Department is suspending 20 Biden-era legal opinions, including one leading to fines against energy companies if birds die in oil spills or other industrial activities. By Catrin ...
Behind PEOPLE's Revealing Interview and Cover Story with Meghan Markle Meghan Markle on 'Day Dates' with Son Archie, 5, and Why Daughter Lilibet, 3, Appears on Her New Website (Exclusive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback